BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21934232)

  • 1. Chronic myelogenous leukemia in sickle cell/beta 0-thalassemia.
    Sallam MM; Alsuliman AM; Alahmed HE; Alabdulaali MK
    Indian J Pathol Microbiol; 2011; 54(3):597-8. PubMed ID: 21934232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic myelogenous leukemia showing biphenotypic blast crisis followed by lineage switch to B lymphoblastic leukemia.
    Oh SH; Park TS; Kim HR; Lee JY; Kim JH; Shin JH; Lee JN
    Leuk Res; 2009 Nov; 33(11):e195-8. PubMed ID: 19446879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary study of HLA-ABCDR antigens in CML, ANLL, thalassemia and severe aplastic anemia in Thais.
    Chiewsilp P; Sujirachato K; Mongkolsuk T; Junpong S; Jootar S; Hathirat P
    J Med Assoc Thai; 2000 Mar; 83 Suppl 1():S130-6. PubMed ID: 10865419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of molecular variants of BCR-ABL gene in bone marrow and blood of patients with chronic myeloid leukemia by reverse-transcriptase polymerase chain reaction (RT-PCR).
    Udomsakdi-Auewarakul C; U-Pratya Y; Boonmoh S; Vatanavicharn S
    J Med Assoc Thai; 2000 Aug; 83(8):928-35. PubMed ID: 10998848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical development of beta-thalassemia-sickle cell anemia apropos of 36 cases].
    Thuret I; Michel G; Lena-Russo D; Orsini A; Perrimond H
    Pediatrie; 1992; 47(12):829-34. PubMed ID: 1338928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sickle cell/β0-thalassemia associated with the 1393 bp deletion can be associated with a severe phenotype.
    Daniel Y; Hill K; Inusa B; Thein SL; Howard J
    Hemoglobin; 2011; 35(4):406-10. PubMed ID: 21797706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensorineural hearing loss in sickle cell disease patients in Sicily.
    Samperi P; Bertuna G; Rossi G; Poli G; Serra A
    Minerva Pediatr; 2005 Oct; 57(5):285-8. PubMed ID: 16205613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
    Betticher DC; Huxol H; Müller R; Speck B; Nissen C
    Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of sickle cell anemia in the Northern Brazilian state of Pará.
    De Lemos Cardoso G; Guerreiro JF
    Am J Hum Biol; 2010; 22(5):573-7. PubMed ID: 20737602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [beta-thalassemia minor diagnosed in a patient with chronic myelogenous leukemia during hydroxyurea therapy].
    Chiba K; Kurosawa M; Kondo T; Suzuki S; Musashi M; Asaka M; Imamura M; Hattori Y; Oba Y
    Rinsho Ketsueki; 2000 Jan; 41(1):61-4. PubMed ID: 10695401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec). Bone marrow histopathology and correlation with genetic status.
    Frater JL; Tallman MS; Variakojis D; Druker BJ; Resta D; Riley MB; Hrisinko MA; Peterson LC
    Am J Clin Pathol; 2003 Jun; 119(6):833-41. PubMed ID: 12817431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.
    Xubo G; Xingguo L; Xianguo W; Rongzhen X; Xibin X; Lin W; Lei Z; Xiaohong Z; Genbo X; Xiaoying Z
    Eur J Haematol; 2009 Oct; 83(4):292-301. PubMed ID: 19500135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusional iron burden and liver toxicity after bone marrow transplantation for acute myelogenous leukemia and hemoglobinopathies.
    Jastaniah W; Harmatz P; Pakbaz Z; Fischer R; Vichinsky E; Walters MC
    Pediatr Blood Cancer; 2008 Feb; 50(2):319-24. PubMed ID: 17557314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Undifferentiated blastic cell crisis of chronic myelogenous leukemia with myeloblastic tumor in the skin].
    Kawakami K; Kiyosaki M; Amaya H; Nakamaki T; Hino K; Tomoyasu S
    Rinsho Ketsueki; 2000 Apr; 41(4):334-40. PubMed ID: 10846465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
    González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
    Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Philadelphia negative, Bcr-Abl positive chronic myeloid leukemia associated with pure red cell aplasia.
    Karti S; Yilmaz M; Sonmez M; Akdogan R; Ersoz S; Ucar F; Ovali E
    J Exp Clin Cancer Res; 2003 Jun; 22(2):341-2. PubMed ID: 12866588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal diagnosis of sickle cell anemia and beta-thalassemia in southern Turkey.
    Cürük MA; Zeren F; Genç A; Ozavci-Aygün S; Kilinç Y; Aksoy K
    Hemoglobin; 2008; 32(6):525-30. PubMed ID: 19065329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute bilineage leukemia after chronic myelogenous leukemia.
    Williams SR; Wellhausen SR; Barker RL; Janckila AJ
    J Ky Med Assoc; 1997 Sep; 95(9):393-6. PubMed ID: 9322413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensive bone marrow necrosis and symptomatic hypercalcemia in B cell blastic transformation of chronic myeloid leukemia: report of a case and review of the literature.
    Noguchi M; Oshimi K
    Acta Haematol; 2007; 118(2):111-6. PubMed ID: 17641550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic myeloid leukemia manifesting as gout. Reflections on secondary gout in Black Africa].
    Mijiyawa M; Segbena A; David M
    Med Trop (Mars); 1995; 55(2):154-6. PubMed ID: 7564998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.